FGFR3, HRAS, KRAS, NRAS and PIK3CA Mutations in Bladder Cancer and Their Potential as Biomarkers for Surveillance and Therapy
PLoS ONE - United States
doi 10.1371/journal.pone.0013821
Full Text
Open PDFAbstract
Available in full text
Categories
Date
November 3, 2010
Authors
Publisher
Public Library of Science (PLoS)